Ultralife Corp
ULBI Nasdaq· Miscellaneous Electrical Machinery, Equipment & Supplies
Last close · Oct 26, 2026
$6.01
KIRA · Stoqly’s AI analyst, in plain words
- Ultralife Corp had $191M of revenue in fiscal 2025, up 16.2% on the year before. Over five years, revenue changed +12.2% a year on average.
- Its operating margin was −3.1%, down 9.1 pts: of every 100 in sales, about −3 is left after running the business.
- Ultralife Corp lost $5.9M in fiscal 2025.
- Free cash flow was $7.1M in fiscal 2025, 3.7% of revenue.
- Ultralife Corp owes $40.3M more than it holds in cash.
Market cap
$100M
P/E
—
Revenue
$191M
Net income
−$5.9M
Free cash flow
$7.1M
Operating margin
−3.1%
Ultralife Corp in 30 seconds · fiscal 2025
Are sales growing?
+16.2%
Yes. Sales grew 16.2% last year.
Does it make a profit?
−3.1%
No. It lost money last year.
Does profit turn into cash?
3.7%
Partly. 3.7% of sales ends up as free cash.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Ultralife Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 23, 2026
- Legal name
- ULTRALIFE CORP
- CIK
- 0000875657
Ultralife Corp · ULBI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $98.3M | $132M | $159M | $164M | $191M |
| Revenue growth | −8.8% | 34.2% | 20.3% | 3.7% | 16.2% |
| Gross margin | 25.1% | 22.3% | 24.7% | 25.7% | 24.1% |
| Operating margin | 0.0% | 0.1% | 6.0% | 6.1% | −3.1% |
| Net income | −$0.2M | −$0.1M | $7.2M | $6.3M | −$5.9M |
| Net margin | −0.2% | −0.1% | 4.5% | 3.8% | −3.1% |
| Diluted EPS | $0.05 | $0.05 | $0.44 | $38.00 | −$35.00 |
| Cash | |||||
| Cash from operations | $4.3M | −$1.3M | $1.9M | $16.6M | $11.0M |
| Capital expenditure | $2.8M | $1.7M | $2.6M | $1.9M | $3.9M |
| Free cash flow | $1.5M | −$2.9M | −$0.6M | $14.7M | $7.1M |
| FCF margin | 1.5% | −2.2% | −0.4% | 8.9% | 3.7% |
| Share count change | 99,508.7% | 0.5% | 0.6% | 3.3% | −0.7% |
| Debt and strength | |||||
| Cash and short-term investments | $8.3M | $5.6M | $10.2M | $6.9M | $9.3M |
| Debt incl. finance leases | $20.9M | $21.5M | $25.7M | $55.0M | $49.7M |
| Shareholders' equity | $118M | $116M | $125M | $134M | $130M |
| Net debt / EBITDA | 3.5x | 3.5x | 1.2x | 3.7x | — |
| Current ratio | 3.5x | 2.7x | 3.8x | 3.3x | 2.8x |
| Returns and quality | |||||
| Return on capital | 0.0% | 0.1% | 5.3% | 4.2% | −2.7% |
| Return on equity | −0.2% | −0.1% | 6.0% | 4.9% | −4.5% |
| Return on tangible equity | −0.4% | −0.2% | 9.9% | 9.8% | −8.0% |
| Piotroski F-score | 3 | 3 | 6 | 4 | 5 |
| Altman Z'' | 3.9 | 3.4 | 4.5 | 3.4 | 2.9 |
Insiders bought, 12 months
$2.5M
4 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Ultralife Corp · ULBI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $6.01 a share, the company is worth $100M.
Source: SEC EDGAR XBRL filings (CIK 0000875657). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.